purpose evaluate toxicity efficacy carbon ion radiotherapy cirt locally advanced cervical cancer phase clinical trials methods materials june NUMBER january NUMBER NUMBER patients treated cirt thirty patients stage iiib disease NUMBER patients stage iva disease median tumor size NUMBER cm range cm treatment consisted NUMBER fractions pelvic irradiation NUMBER fractions local boost study total dose ranged NUMBER NUMBER gray equivalents gye gye fraction second study pelvic dose fixed NUMBER gye additional NUMBER NUMBER gye given cervical tumor total dose NUMBER NUMBER gye results patient developed severe acute toxicity contrast NUMBER patients developed major late gastrointestinal complications doses resulting major complications NUMBER gye patients major complications surgically salvaged local control rate patients second studies NUMBER NUMBER respectively treated NUMBER gye local control favorable patients stage iva disease NUMBER tumors NUMBER cm NUMBER conclusions cirt advanced cervical cancer dose intestines limited NUMBER gye avoid major complications number patients study small results support continued investigation confirm therapeutic efficacy NUMBER NUMBER NUMBER NUMBER NUMBER year ii